CoChat

Ablation of Transcription Factor IRF4 Promotes Transplant Acceptance by Driving Allogenic CD4+ T Cell Dysfunction

Open access
Wu, Jie, Zhang, Hedong, Shi, Xiaomin, Xiao, Xiang, Fan, Yihui, Minze, Laurie J., Wang, Jin, Ghobrial, Rafik M., Xia, Jiahong, Sciammas, Roger, Li, Xian C., Chen, Wenhao · 2017 · Immunity
Cited by 92

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Summary CD4+ T cells orchestrate immune responses and destruction of allogeneic organ transplants, but how this process is regulated on a transcriptional level remains unclear. Here, we demonstrated that interferon regulatory factor 4 (IRF4) was a key transcriptional determinant controlling T cell responses during transplantation. IRF4 deletion in mice resulted in progressive establishment of CD4+ T cell dysfunction and long‐term allograft survival. Mechanistically, IRF4 repressed PD‐1, Helios, and other molecules associated with T cell dysfunction. In the absence of IRF4, chromatin accessibility and binding of Helios at PD‐1 cis‐regulatory elements were increased, resulting in enhanced PD‐1 expression and CD4+ T cell dysfunction. The dysfunctional state of Irf4‐deficient T cells was initially reversible by PD‐1 ligand blockade, but it progressively developed into an irreversible state. Hence, IRF4 controls a core regulatory circuit of CD4+ T cell dysfunction, and targeting IRF4 represents a potential therapeutic strategy for achieving transplant acceptance. Graphical Abstract Figure. No caption available. HighlightsAblation of IRF4 induces transplant acceptance by establishing T cell dysfunctionIRF4 represses PD‐1, Helios, and other molecules associated with T cell dysfunctionIrf4-/- T cell dysfunction is initially reversible but later becomes irreversibleTrametinib inhibits IRF4, abrogates EAE development, and prolongs allograft survival &NA; CD4+ T cells drive allogeneic organ transplant destruction, but how this is regulated transcriptionally remains unclear. Wu et al. report that IRF4 deletion in T cells leads to the establishment of T cell dysfunction and long‐term allograft survival. Therefore, targeting IRF4 represents a therapeutic opportunity for achieving transplant acceptance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.immuni.2017.11.003

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 92

Metadata

Authors
Wu, J., Zhang, H., Shi, X., Xiao, X., Fan, Y., Minze, L. J., Wang, J., Ghobrial, R. M., Xia, J., Sciammas, R., Li, X. C., & Chen, W.
Venue
Immunity
Publisher
Elsevier BV
Published
2017-12
Volume
47
Issue
6
Pages
1114-1128.e6
ISSN
1074-7613 (ISSN-L)
OpenAlex
W2773141414
Cited by
92
References
9
FWCI
3.35
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ablation of Transcription Factor IRF4 Promotes Transplant Acceptance by Driving Allogenic CD4+ T Cell Dysfunction. https://app.cochat.ai/papers/10.1016/j.immuni.2017.11.003
The paper
Wu, J., Zhang, H., Shi, X., Xiao, X., Fan, Y., Minze, L. J., Wang, J., Ghobrial, R. M., Xia, J., Sciammas, R., Li, X. C., & Chen, W. (2017). Ablation of Transcription Factor IRF4 Promotes Transplant Acceptance by Driving Allogenic CD4+ T Cell Dysfunction. Immunity. https://doi.org/10.1016/j.immuni.2017.11.003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.